Phase I/II Trial of Vorinostat and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer.

Trial Profile

Phase I/II Trial of Vorinostat and Radiation Therapy in Patients With Locally Advanced Pancreatic Cancer.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 27 Feb 2012

At a glance

  • Drugs Vorinostat (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Oct 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 19 May 2010 New source identified and integrated (M.D. Anderson Cancer Center, 2008-0780).
    • 14 May 2009 Actual initiation date (May 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top